134 related articles for article (PubMed ID: 67161)
1. Plasma cell antigens in human multiple myeloma.
Mackenzie MR; Paglieroni TG
J Lab Clin Med; 1977 May; 89(5):1009-17. PubMed ID: 67161
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma: an immunologic profile. II. Bone marrow studies.
Paglieroni T; MacKenzie MR; Caggiano V
J Natl Cancer Inst; 1978 Oct; 61(4):943-50. PubMed ID: 151751
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: an immunologic profile. I. Peripheral blood studies.
MacKenzie MR; Paglieroni T
J Immunol; 1977 May; 118(5):1864-71. PubMed ID: 140196
[TBL] [Abstract][Full Text] [Related]
4. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
[TBL] [Abstract][Full Text] [Related]
5. An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.
Nathan PD; Walker L; Hardie D; Richardson P; Khan M; Johnson GD; Ling NR
Clin Exp Immunol; 1986 Jul; 65(1):112-9. PubMed ID: 3024883
[TBL] [Abstract][Full Text] [Related]
6. Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
Tarte K; Zhang XG; Legouffe E; Hertog C; Mehtali M; Rossi JF; Klein B
J Immunol; 1999 Jul; 163(1):514-24. PubMed ID: 10384156
[TBL] [Abstract][Full Text] [Related]
7. Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes.
Horwitz DA; Garrett MA
J Immunol; 1977 May; 118(5):1712-21. PubMed ID: 140193
[TBL] [Abstract][Full Text] [Related]
8. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
[TBL] [Abstract][Full Text] [Related]
9. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL
Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238
[TBL] [Abstract][Full Text] [Related]
10. Studies on the pathogenesis of an immune defect in multiple myeloma.
Paglieroni T; MacKenzie MR
J Clin Invest; 1977 Jun; 59(6):1120-33. PubMed ID: 16939
[TBL] [Abstract][Full Text] [Related]
11. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
12. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
13. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
Hagner G
Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytotoxicity in vitro: target-cell recognition and effector-cell requirements.
Perlmann P; Holm G; Stejskal V
Transplant Proc; 1973 Dec; 5(4):1625-9. PubMed ID: 4272822
[No Abstract] [Full Text] [Related]
17. Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
Katodritou E; Terpos E; North J; Kottaridis P; Verrou E; Gastari V; Chadjiaggelidou C; Sivakumaran S; Jide-Banwo S; Tsirogianni M; Kapetanos D; Zervas K; Lowdell MW
Am J Hematol; 2011 Dec; 86(12):967-73. PubMed ID: 21919039
[TBL] [Abstract][Full Text] [Related]
18. Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.
Han T; Dadey B; Minowada J; Golde DW
Immunology; 1979 Sep; 38(1):63-8. PubMed ID: 159862
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals.
Fauci AS
J Clin Invest; 1975 Jul; 56(1):98-110. PubMed ID: 1079808
[TBL] [Abstract][Full Text] [Related]
20. Light chain myeloma plasma cells induce a strong cell-mediated immune response mainly directed against the monoclonal light chain determinants in a murine experimental model.
Galea HR; Denizot Y; Cogné M
Cancer Immunol Immunother; 2002 Jun; 51(4):229-34. PubMed ID: 12012110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]